Sydney Lupkin | MDedge

Drugmakers blamed for blocking generics have cost U.S. billions

Publish date: May 23, 2018

By delaying development of generics, drugmakers can maintain their monopolies and keep prices high.

Publish date: April 6, 2018

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.

Publish date: August 14, 2017

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the...

Publish date: April 24, 2017

Pharmaceutical companies are “going all in” to fight reduced drug prices and other opposition in Washington.

Publish date: March 15, 2017

President Donald Trump’s pick to lead the Food and Drug Administration has deep ties to the pharmaceutical industry as a consultant, investor, and...